Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Multi-month dispensing (MMD)"'
Autor:
Ramona Scherrer, Nadine Tschumi, Thabo Ishmael Lejone, Mathebe Kopo, Lipontso Motaboli, Buoang Mothobi, Alain Amstutz, Michael J. Deml, Malebanye Lerotholi, Niklaus Daniel Labhardt
Publikováno v:
Pilot and Feasibility Studies, Vol 8, Iss 1, Pp 1-10 (2022)
Abstract Background Multi-month dispensing (MMD) of antiretroviral therapy (ART) represents one approach of differentiated service delivery (DSD) aiming to improve quality and cost-effectiveness for HIV services in resource-limited settings. However,
Externí odkaz:
https://doaj.org/article/fa59530327cc44e2b58d3556925e5860
Autor:
Silviu Tomescu, Thomas Crompton, Jonathan Adebayo, Constance Wose Kinge, Francis Akpan, Marcus Rennick, Charles Chasela, Evans Ondura, Dauda Sulaiman Dauda, Pedro T. Pisa
Publikováno v:
BMC Public Health, Vol 21, Iss 1, Pp 1-8 (2021)
Abstract Background Patient interruption of antiretroviral therapy (ART) continues to limit HIV programs’ progress toward epidemic control. Multiple factors have been associated with client interruption in treatment (IIT)— including age, gender,
Externí odkaz:
https://doaj.org/article/181832d58fcf409b83dd6a814e841522
Autor:
Scherrer, Ramona, Tschumi, Nadine, Lejone, Thabo Ishmael, Kopo, Mathebe, Motaboli, Lipontso, Mothobi, Buoang, Amstutz, Alain, Deml, Michael, Lerotholi, Malebanye, Labhardt, Niklaus Daniel
Publikováno v:
Pilot and Feasibility Studies
Pilot and feasibility studies, Vol. 8, No 1 (2022) P. 61
Pilot and feasibility studies, Vol. 8, No 1 (2022) P. 61
Background Multi-month dispensing (MMD) of antiretroviral therapy (ART) represents one approach of differentiated service delivery (DSD) aiming to improve quality and cost-effectiveness for HIV services in resource-limited settings. However, reductio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c968eb0517f86ee246323e23b61a8f8
http://hdl.handle.net/11427/36345
http://hdl.handle.net/11427/36345
Autor:
Charles Chasela, Constance Wose Kinge, Francis Akpan, Jonathan Adebayo, Silviu Tomescu, Pedro T Pisa, Thomas Crompton, Evans Ondura, Dauda Sulaiman Dauda, Marcus Rennick
Publikováno v:
BMC Public Health
BMC Public Health, Vol 21, Iss 1, Pp 1-8 (2021)
BMC Public Health, Vol 21, Iss 1, Pp 1-8 (2021)
Background Patient interruption of antiretroviral therapy (ART) continues to limit HIV programs’ progress toward epidemic control. Multiple factors have been associated with client interruption in treatment (IIT)— including age, gender, CD4 count
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Scherrer R; Clinical Research Unit, Department Medicine, Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland., Tschumi N; Clinical Research Unit, Department Medicine, Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland., Lejone TI; SolidarMed, Swiss Organization for Health in Africa, Butha-Buthe, Lesotho., Kopo M; SolidarMed, Swiss Organization for Health in Africa, Butha-Buthe, Lesotho., Motaboli L; SolidarMed, Swiss Organization for Health in Africa, Butha-Buthe, Lesotho., Mothobi B; SolidarMed, Swiss Organization for Health in Africa, Butha-Buthe, Lesotho., Amstutz A; Clinical Research Unit, Department Medicine, Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland.; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland., Deml MJ; Institute of Sociological Research, Department of Sociology, University of Geneva, Geneva, Switzerland.; Division of Social and Behavioural Sciences, School of Public Health & Family Medicine, University of Cape Town, Cape Town, South Africa., Lerotholi M; Ministry of Health of Lesotho, Maseru, Lesotho., Labhardt ND; Clinical Research Unit, Department Medicine, Swiss Tropical and Public Health Institute, Basel, Switzerland. n.labhardt@unibas.ch.; University of Basel, Basel, Switzerland. n.labhardt@unibas.ch.; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland. n.labhardt@unibas.ch.
Publikováno v:
Pilot and feasibility studies [Pilot Feasibility Stud] 2022 Mar 11; Vol. 8 (1), pp. 61. Date of Electronic Publication: 2022 Mar 11.